Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"610"
publishDate:"[2020 TO 2020]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
PubPharm (838)
1
A Phase 2 Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with uncontrolled asthma : A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Corticosteroids and at least one additional asthma controller (CASCADE) - CASCADE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
2
A Randomized Study Comparing JNJ-68284528 versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma : A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA, versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma - CARTITUDE-4
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
3
Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma (SOURCE) : A Multicentre, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma (SOURCE) - SOURCE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
4
A Phase 2 Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with uncontrolled asthma : A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Corticosteroids and at least one additional asthma controller (CASCADE) - CASCADE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
5
A Randomized Study Comparing JNJ-68284528 versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma : A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA, versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma - CARTITUDE-4
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
6
Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma (SOURCE) : A Multicentre, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma (SOURCE) - SOURCE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
7
A study of a combination of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B-Pd) compared to Bortezomib with Pomalidomide and Dexamethasone (PVd) in Participants with Relapsed/Refractory Multiple Myeloma : A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone (B-Pd) versus Pomalidomide plus Bortezomib and Dexamethasone (PVd) in Participants with Relapsed/Refractory Multiple Myeloma (DREAMM 8) - DREAMM-8 (ACRONYM)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
A study of belantamab mafodotin compared to a combination of pomalidomide and dexamethasone in participants with relapsed/refractory multiple myeloma : A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3) - GSK_207495
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
9
A study of a combination of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B-Pd) compared to Bortezomib with Pomalidomide and Dexamethasone (PVd) in Participants with Relapsed/Refractory Multiple Myeloma : A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone (B-Pd) versus Pomalidomide plus Bortezomib and Dexamethasone (PVd) in Participants with Relapsed/Refractory Multiple Myeloma (DREAMM 8) - DREAMM-8 (ACRONYM)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
A study of belantamab mafodotin compared to a combination of pomalidomide and dexamethasone in participants with relapsed/refractory multiple myeloma : A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3) - GSK_207495
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[84]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: 610
Filter aufheben
Erscheinungsjahr: 2020-2020
Medienart
838
Aufsätze
838
E-Artikel
838
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
610
824
Study Type: Interventional
302
Recruitment Status: Not yet recruiting
270
Phase: Phase 3
194
Recruitment Status: Authorised-recruitment may ...
168
Recruitment Status: Completed
144
Phase: Phase 2
140
Recruitment Status: Recruiting
98
Phase: Phase 4
38
Phase: Phase 2/Phase 3
36
Phase: Phase 1
30
Medical Condition: Multiple Myeloma MedDRA vers...
20
Medical Condition: Asthma; Asthma;Respiratory -...
18
Recruitment Status: Stopped early
16
Medical Condition: Asthma MedDRA version: 20.0L...
14
Medical Condition: Relapsed/Refractory Multiple...
14
Study Type: Observational
12
Medical Condition: Atopic Dermatitis MedDRA ver...
12
Medical Condition: Multiple Myeloma; Multiple M...
10
Medical Condition: Male or female, 18 years of ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
826
Englisch
12
Unbestimmt
Haven't found what you're looking for?
Wird geladen...